SCHEMBL27595486

SCHEMBL27595486

O=[C]c1c[nH]c2c(Cl)ccnc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 1/20 0.45
▸ KDM4C Q9H3R0 1/20 0.45
▸ LRRK2 Q5S007 4/20 0.42
▸ DAO P14920 1/20 0.40
▸ DYRK1A Q13627 3/20 0.38
▸ AXL P30530 2/20 0.34
▸ PRKCI P41743 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ AURKA O14965 1/20 0.31
▸ CDC7 O00311 1/20 0.30
▸ PLK4 O00444 1/20 0.30
▸ CHEK1 O14757 1/20 0.30
▸ MAPK13 O15264 1/20 0.30
▸ PDPK1 O15530 1/20 0.30
▸ DAPK3 O43293 1/20 0.30
▸ DYRK3 O43781 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13903470 0.73 KDM5A (0.46) KDM5AKDM4CLRRK2DAODYRK1A
SCHEMBL28380264 0.72 MAPK1 (0.48) KDM5AKDM4CLRRK2DAODYRK1A
SCHEMBL16593421 0.72 KDM5A (0.45) KDM5AKDM4CLRRK2DAODYRK1A
SCHEMBL13909686 0.71 KDM5A (0.45) KDM5AKDM4CLRRK2DAODYRK1A
SCHEMBL27595634 0.70 KDM5A (0.47) KDM5AKDM4CLRRK2DAODYRK1A
SCHEMBL17128283 0.70 KDM5A (0.44) KDM5AKDM4CLRRK2DAODYRK1A
SCHEMBL6733348 0.70 KDM4C (0.69) KDM5AKDM4CDAOKDM4EALDH1A1
SCHEMBL21042568 0.69 KDM5A (0.54) KDM5AKDM4CLRRK2DAOAXL
SCHEMBL13903471 0.69 ALDH1A1 (0.54) KDM5AKDM4CDAODYRK1AKDM4E
SCHEMBL1472608 0.68 KDM5A (0.56) KDM5AKDM4CLRRK2DAODYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101229164-B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives BRISTOL MYERS SQUIBB CO 2013-01-02 — — CN disclosed
CN-100384423-C Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2008-04-30 — — CN disclosed
CN-100379421-C Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2008-04-09 — — CN disclosed
CN-1688311-A Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2005-10-26 — — CN disclosed
CN-1612763-A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2005-05-04 — — CN disclosed
Send feedback